US Oncology Reports Third Quarter 20... ( HOUSTON Nov. 6 /- US Oncology Inc...)

US Oncology Reports Third Quarter 2008 Results

Date:11/6/2008

HOUSTON, Nov. 6 /PRNewswire/ -- US Oncology, Inc. ("US Oncology" or "the Company"), one of the nation's largest cancer care services companies, reported revenue of $821.7 million, EBITDA of $54.5 million, Adjusted EBITDA of $54.8 million, net income of $3.9 million and operating cash flow of $35.1 million for the three months ended September 30, 2008. For the nine months ended September 30, 2008, US Oncology reported revenue of $2.5 billion, EBITDA of $(217.7) million, Adjusted EBITDA of $164.4 million, net loss of $371.0 million and operating cash flow of $77.3 million.

US Oncology Third Quarter Results

-- Adjusted EBITDA for the third quarter of 2008 was $54.8 million,

compared to $50.6 million for the third quarter of 2007 and $57.4

million for the second quarter of 2008. The increase from the third

quarter of 2007 reflects an increase in daily patient visits and

radiation treatments/diagnostic scans at practices affiliated under

comprehensive service agreements ("CSA"), as well as

improvements in pharmaceutical performance and volume related fees,

partially offset by reduced utilization of Erythropoiesis-Stimulating

Agents ("ESAs"). The decrease from the previous quarter is

primarily due to reduced earnings from ESAs (see "Contingencies and

Risks").

-- Cash flow from operations in the third quarter of 2008 was $35.1

million, compared to cash generated by operations of $16.5 million for

the third quarter of 2007 and cash used for operations of $(8.6) million

for the second quarter of 2008. The $18.6 million increase in operating

cash flow from the third quarter of 2007 reflects the addition of

physicians to our network and increasing daily same store visits, as

well as higher receivable collections in the current quarter. The $43.7

million increase f
'/>"/>

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23
Related medicine news :

1. OncologyRx Care Advantage(TM) Specialty Pharmacy Passes $10 Million Milestone in Patient Financial Assistance
2. Premier Radiation Oncology Meeting Breaks Attendance, Exhibit Space Record at Boston Meeting
3. Radiation Oncology Experts from 16 Countries Attend Technical University of Munich's International Conference on TomoTherapy
4. US Oncologys Innovent Oncology Division Announces First Agreement Between Rocky Mountain Cancer Centers and Colorado Public Employees Retirement Association
5. Biosimilar Monoclonal Antibodies in Oncology Will Approach Blockbuster Status by 2017
6. Radiation Oncology Services of America, Inc. Announces Formation of Scientific Advisory Board
7. US Oncology Appoints Michael A. Sicuro Executive Vice President and Chief Financial Officer
8. Radiation Oncology Institute Campaign Raises $3 Million
9. Dr. Chad Levitt Joins North Georgia Radiation Oncology Center
10. Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development
11. US Oncology Launches New Services Division: Innovent Oncology

Post Your Comments:

US Oncology Reports Third Quarter 20...( HOUSTON Nov. 6 /- US Oncology Inc...),Health